MORGAN STANLEY PLC/PUT/PFIZER INC/25/0.1/16.01.26 Stock

Warrant

DE000ME66ZQ6

Real-time Bid/Ask 12:13:11 2024-07-12 EDT
0.217 EUR / 0.219 EUR -3.54% Intraday chart for MORGAN STANLEY PLC/PUT/PFIZER INC/25/0.1/16.01.26
Current month-5.44%
3 months-31.52%
Date Price Change
24-07-12 0.216 -4.42%
24-07-11 0.226 -3.42%
24-07-10 0.234 -6.40%
24-07-09 0.25 +4.17%
24-07-08 0.24 -1.64%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 11:12 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN ME66ZQ
ISINDE000ME66ZQ6
Date issued 2024-01-02
Strike 25 $
Maturity 2026-01-16 (553 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.41
Lowest since issue 0.188
Spread 0.002
Spread %0.91%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66 USD
Average target price
32.01 USD
Spread / Average Target
+11.68%
Consensus